EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Apures Co's enterprise value is ₩21,960.7 Mil.
Apures Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩658.9 Mil. Therefore, Apures Co's EV-to-Revenue for today is 33.33.
The historical rank and industry rank for Apures Co's EV-to-Revenue or its related term are showing as below:
XKRX:149300'
s EV-to-Revenue Range Over the Past 10 Years
Min: 28.39 Med: 82.55 Max: 251.3
Current: 33.33
During the past 10 years, the highest EV-to-Revenue of Apures Co was 251.30. The lowest was 28.39. And the median was 82.55.
XKRX:149300's EV-to-Revenue is ranked worse than 91.96% of 224
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.24
vs XKRX:149300: 33.33
As of today (2024-05-13), Apures Co's stock price is ₩384.00.
Apures Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩16.91. Therefore, Apures Co's PS Ratio for today is 22.71.
Apures Co EV-to-Revenue Historical Data
The historical data trend for Apures Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Apures Co's EV-to-Revenue
For the Diagnostics & Research subindustry, Apures Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apures Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Apures Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Apures Co's EV-to-Revenue falls into.
Apures Co's current Enterprise Value is ₩21,960.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apures Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩658.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apures Co's share price for today is ₩384.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩16.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apures Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Apures Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:149300 has been successfully added to your 